<VariationArchive VariationID="208586" VariationName="NM_024747.6(HPS6):c.238dup (p.Asp80fs)" VariationType="Duplication" Accession="VCV000208586" Version="15" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-23" DateCreated="2015-09-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="205193" VariationID="208586">
      <GeneList>
        <Gene Symbol="HPS6" FullName="HPS6 biogenesis of lysosomal organelles complex 2 subunit 3" GeneID="79803" HGNC_ID="HGNC:18817" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>10q24.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102065349" stop="102068036" display_start="102065349" display_stop="102068036" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="103825123" stop="103827794" display_start="103825123" display_stop="103827794" Strand="+" />
          </Location>
          <OMIM>607522</OMIM>
        </Gene>
        <Gene Symbol="LOC130004578" FullName="ATAC-STARR-seq lymphoblastoid silent region 2738" GeneID="130004578" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>10q24.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102065101" stop="102065770" display_start="102065101" display_stop="102065770" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_024747.6(HPS6):c.238dup (p.Asp80fs)</Name>
      <CanonicalSPDI>NC_000010.11:102065710:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>10q24.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102065710" stop="102065711" display_start="102065710" display_stop="102065711" variantLength="1" positionVCF="102065710" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="103825467" stop="103825468" display_start="103825467" display_stop="103825468" variantLength="1" positionVCF="103825467" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>D80fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.103825469dup" Assembly="GRCh37">
            <Expression>NC_000010.10:g.103825469dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.102065712dup" Assembly="GRCh38">
            <Expression>NC_000010.11:g.102065712dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012029.1" sequenceAccession="NG_012029" sequenceVersion="1" change="g.5323dup">
            <Expression>NG_012029.1:g.5323dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024747.6" sequenceAccession="NM_024747" sequenceVersion="6" change="c.238dup" MANESelect="true">
            <Expression>NM_024747.6:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079023.2" sequenceAccession="NP_079023" sequenceVersion="2" change="p.Asp80fs">
            <Expression>NP_079023.2:p.Asp80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_564" sequenceAccession="LRG_564">
            <Expression>LRG_564:g.5323dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_564t1" sequenceAccession="LRG_564t1">
            <Expression>LRG_564t1:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_564p1" sequenceAccession="LRG_564p1" change="p.Asp80fs">
            <Expression>LRG_564p1:p.Asp80fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024747.5" sequenceAccession="NM_024747" sequenceVersion="5" change="c.238dupG">
            <Expression>NM_024747.5:c.238dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA276007" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607522.0005" DB="OMIM" />
        <XRef Type="rs" ID="281865108" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024747.6(HPS6):c.238dup (p.Asp80fs) AND Hermansky-Pudlak syndrome 6" Accession="RCV000190593" Version="12">
        <ClassifiedConditionList TraitSetID="804">
          <ClassifiedCondition DB="MedGen" ID="C3888007">Hermansky-Pudlak syndrome 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2018-11-14" SubmissionCount="3">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024747.6(HPS6):c.238dup (p.Asp80fs) AND Hermansky-Pudlak syndrome" Accession="RCV000851747" Version="1">
        <ClassifiedConditionList TraitSetID="6264">
          <ClassifiedCondition DB="MedGen" ID="C0079504">Hermansky-Pudlak syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024747.6(HPS6):c.238dup (p.Asp80fs) AND not provided" Accession="RCV001857672" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-30" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2015-09-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(2); Likely pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">12548288</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17041891</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19843503</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(2); Likely pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2019-05-24">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-01-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-01-25">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6264" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2033" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome</ElementValue>
                <XRef ID="Hermansky-Pudlak+syndrome/3391" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019312" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS203300" DB="OMIM" />
                <XRef ID="9311003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6643" />
                <XRef ID="6643" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C0079504" DB="MedGen" />
              <XRef ID="MONDO:0019312" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS203300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="804" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9854" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome 6</ElementValue>
                <XRef ID="Hermansky-Pudlak+syndrome+6/8540" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013558" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS6</ElementValue>
                <XRef Type="MIM" ID="614075" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18335" />
                <XRef ID="18335" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <XRef ID="231512" DB="Orphanet" />
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C3888007" DB="MedGen" />
              <XRef ID="MONDO:0013558" DB="MONDO" />
              <XRef Type="MIM" ID="614075" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50198" SubmissionDate="2017-07-28" DateLastUpdated="2015-09-14" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607522.0005_HERMANSKY-PUDLAK SYNDROME 6" title="HPS6, 1-BP DUP, 238G_HERMANSKY-PUDLAK SYNDROME 6" />
        <ClinVarAccession Accession="SCV000044942" DateUpdated="2015-09-14" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 13-year-old girl of German and Dutch descent with Hermansky-Pudlak syndrome-6 (HPS6; 614075), Huizing et al. (2009) identified compound heterozygosity for 2 mutations in the HPS6 gene: a 1-bp duplication (238dupG), resulting in a frameshift and premature termination, and an 815C-T transition, resulting in a thr272-to-ile (T272I; 607522.0006) substitution in a highly conserved region. The T272I mutation was not found in 484 control chromosomes.</Attribute>
              <Citation>
                <ID Source="PubMed">19843503</ID>
              </Citation>
              <XRef DB="OMIM" ID="614075" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPS6" />
          </GeneList>
          <Name>HPS6, 1-BP DUP, 238G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 238G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607522.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HERMANSKY-PUDLAK SYNDROME 6</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1769276" SubmissionDate="2019-03-28" DateLastUpdated="2019-09-29" DateCreated="2019-09-29">
        <ClinVarSubmissionID localKey="c.238dupG_C0079504" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000899618" DateUpdated="2019-09-29" DateCreated="2019-09-29" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">31064749</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>European</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <TypePlatform>Targeted sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">TGP0178</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPS6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024747.5:c.238dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hermansky-Pudlak syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0079504" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <StudyName>ThromboGenomics</StudyName>
        <SubmissionNameList>
          <SubmissionName>ThromboGenomics</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1790527" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="812172" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915456" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19843503</ID>
          </Citation>
          <Comment>The HPS6 c.238dupG (p.Asp80GlyfsTer96) variant results in a frameshift and is predicted to result in premature termination of the protein. The p.Asp80GlyfsTer96 variant has been reported in one study in which it is identified in a compound heterozygous state with a missense variant in one individual diagnosed with Hermansky- Pudlak syndrome (Huizing et al. 2009). Control data are unavailable for this variant which is not found in the 1000 Genomes Project, the Exome Sequencing Project, Exome Aggregation Consortium, or the Genome Aggregation Database. Based on the limited clinical evidence and potential impact of frameshift variants, the c.238dupG (p.Asp80GlyfsTer96) variant is classified as a variant of unknown significance but suspicious for pathogenicity for Hermansky-Pudlak syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPS6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="TG" referenceAllele="T" start="103825467" stop="103825467" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024747.5:c.238dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614075" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="454367" SubmissionDate="2015-08-18" DateLastUpdated="2015-09-14" DateCreated="2015-09-14">
        <ClinVarSubmissionID localKey="55431997|OMIM:614075" />
        <ClinVarAccession Accession="SCV000245620" DateUpdated="2015-09-14" DateCreated="2015-09-14" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-02-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17041891</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12548288</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19843503</ID>
          </Citation>
          <Comment>The p.Asp80GlyfsX96 variant in HPS6 has been reported in 1 compound heterozygous individual with clinical features of Hermansky-Pudlak syndrome (Huizing 2009). Data from large population studies is insufficient to assess the frequency of this variant. This variant is predicted to cause a frameshift, which alters the proteinâ€™s amino acid sequence beginning at position 80 and leads to a premature termination codon 96 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Truncating HPS6 variants have been identified in several homozygous and compound heterozygous individuals with Hermansky-Pudlak syndrome (Zhang 2003, Huizing 2009). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPS6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_024747.4:EXON 1</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_024747.4:c.238dupG</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.103825469_103825470insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hermansky-Pudlak syndrome 6</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="614075" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-MedSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>CSER-MedSeq</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4264323" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4655260|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002245839" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19843503</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17041891</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asp80Glyfs*96) in the HPS6 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 696 amino acid(s) of the HPS6 protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with Hermansky-Pudlak syndrome (PMID: 19843503). ClinVar contains an entry for this variant (Variation ID: 208586). This variant disrupts a region of the HPS6 protein in which other variant(s) (p.Leu356Alafs*11) have been determined to be pathogenic (PMID: 17041891). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPS6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.103825467_103825468insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="454367" TraitType="Disease" MappingType="Name" MappingValue="Hermansky-Pudlak syndrome 6" MappingRef="Preferred">
        <MedGen CUI="C3888007" Name="Hermansky-Pudlak syndrome 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="50198" TraitType="Disease" MappingType="Name" MappingValue="HERMANSKY-PUDLAK SYNDROME 6" MappingRef="Preferred">
        <MedGen CUI="C3888007" Name="Hermansky-Pudlak syndrome 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1790527" TraitType="Disease" MappingType="XRef" MappingValue="614075" MappingRef="OMIM">
        <MedGen CUI="C3888007" Name="Hermansky-Pudlak syndrome 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4264323" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1769276" TraitType="Disease" MappingType="Name" MappingValue="Hermansky-Pudlak syndrome" MappingRef="Preferred">
        <MedGen CUI="C0079504" Name="Hermansky-Pudlak syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

